SAN FRANCISCO, Feb. 28, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, announced that the ...
Learn more about whether iRhythm Technologies, Inc. or Omnicell, Inc. is a better investment based on AAII's A+ Investor ...
Zio XT is recommended as an option for people with suspected cardiac arrhythmias who would benefit from ambulatory electrocardiogram (ECG) monitoring for longer than 24 hours only if NHS organisations ...
SAN FRANCISCO & LONDON--(BUSINESS WIRE)--iRhythm Technologies (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced it is the ...
SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent ...
SAN FRANCISCO, July 18, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent ...
iRhythm Technologies today unveiled initial findings on the post-market and real-world performance of its Zio monitor, building on the devices previous generation of the long-term continuous ...
If you hear somebody mention the word, iRhythm, you might conclude that it' a musical group or a new dance step. But you would be wrong. In fact, iRhythm (IRTC)is in a more serious, life-saving ...
SAN FRANCISCO, March 06, 2023 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent ...
Management has expanded selling, general, and administrative expenses in lockstep with gross profit increases. The aggressive strategy has a cost. Despite the progress and sales growth, investors have ...
iRhythm Technologies is a one-trick pony that is near the peak of its revenue growth trajectory. Devices with extensive processing times like the Zio XT will be obsolete as soon as 2020 depending on ...
3.1 The clinical evidence comprises 17 published studies, which include 169,063 people referred to ambulatory monitoring, and 13 abstracts: 3.2 Three of the 4 comparative studies compared 14‑day Zio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback